This announcement is a separate document:
中國抗體-B：建議重選退任董事及建議授出購回股份及發行股份之一般授權及建議修訂二零二二年購股權計劃及建議更新計劃授權限額及服務提供商分項限額及股東週年大會通告
SINOMAB BIO-B: PROPOSED RE-ELECTION OF RETIRING DIRECTORSANDPROPOSED GRANTING OF GENERAL MANDATES TOBUY BACK SHARES AND TO ISSUE SHARESANDPROPOSED AMENDMENTS TO THE 2022 SHARE OPTION SCHEMEANDPROPOSED REFRESHMENT OF SCHEME MANDATE LIMIT ANDSERVICE PROVIDER SUBLIM
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.